The Urgent Need for Measles and Rubella Eradication

By Melike Belenli Gümüş

August 8, 2024

Introduction

Fifty years after the initiation of the Expanded Programme on Immunization in 1974, life-saving vaccines have reformed global healthcare. Among these, the measles-containing vaccine (MCV) stands out for its unparalleled role in reducing child mortality rates, preventing an estimated 57 million deaths worldwide between 2000 and 2022. Despite significant progress, diseases such as measles and rubella continue to pose a threat, particularly in developing countries. The COVID-19 pandemic has further complicated efforts, highlighting the need for renewed focus and coordinated action. In their recent article, Durrheim et al. indicated the current state of measles and rubella worldwide, the challenges faced, and the strategies required to achieve measles and rubella eradication.

The Current State of Measles and Rubella Vaccination

Measles and rubella remain significant public health concerns. In 2021, only 81% of children received their first dose of the measles-containing vaccine (MCV1), the lowest coverage since 2008. This left 25 million children vulnerable to measles. By 2022, MCV1 coverage had increased slightly to 83%, but this was still below the pre-pandemic level of 86%. The result has been large, disruptive outbreaks in many countries, with a global epidemic curve resembling that of 2018 and early 2019.

Figure 1: Measles reported cases worldwide, 1974–2022. Source: World Health Organization. Global Health Observatory.

Measles not only poses immediate threats but also leads to immunosuppression in children, increasing their susceptibility to other infections. This explains a significant portion of childhood deaths post-measles infection. The measles vaccine is highly cost-effective, with data indicating that for every US$ 1 invested in vaccination from 2001 to 2020, US$ 58 were saved in future costs. Modelling shows that measles vaccination can prevent 37% of deaths from 14 key pathogens between 2021 and 2030, saving 18.8 million lives in this decade alone.

Impact of the COVID-19 Pandemic

The COVID-19 pandemic has had a profound impact on measles and rubella eradication efforts. The pandemic led to the closure of country borders, a dramatic decrease in international travel, and the implementation of wide-scale non-pharmaceutical public health measures. These actions significantly obstructed the importation and transmission of measles and rubella viruses. However, the pandemic also disrupted routine immunisation programmes and postponed vaccination campaigns, creating immunity gaps.

The Immunisation Agenda 2030

The Immunisation Agenda 2030 (IA2030) of the World Health Organization (WHO) recognises measles as a tracer of the strength of immunisation programmes. Strategic priority 3 of IA2030 notes that measles cases and outbreaks should identify weaknesses in immunisation programmes and guide programmatic planning. Nevertheless, IA2030 will inevitably fail unless measles and rubella eradication efforts are accelerated. This includes achieving impact goals such as reducing deaths, endorsing elimination targets, and increasing global coverage with the second dose of the measles-containing vaccine (MCV2) to 90%.

The Moral Imperative for Eradication

There is a moral imperative to commit to and achieve measles and rubella eradication. The ongoing disease burden and preventable deaths due to measles are unacceptable. The rule of rescue demands that if we have effective tools, we should make every effort to save lives. The eradication of measles, rubella, and congenital rubella syndrome (CRS) should not remain as a technically possibility but must be achieved to prevent children from facing avoidable childhood mortality and lifelong disabilities. This completion is essential to secure a future where children are not burdened by these preventable health risks.

Conclusion

Measles and rubella eradication represent a moral imperative and a critical public health goal. The global community must act now to close immunity gaps, strengthen immunisation programmes, and commit to the goals of the Immunisation Agenda 2030. By fostering collaboration, securing adequate resources, and engaging diverse stakeholders, we can ensure a future where preventable childhood diseases like measles and rubella are consigned to history. This action will safeguard the health and well-being of generations to come.

Reference url

Recent Posts

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

HPV testing HNSCC
    

HPV Testing in Head and Neck Squamous Cell Carcinoma

🔍 Are you up-to-date with the latest advancements in HPV testing for head and neck cancer?

Our comprehensive article looks into the innovation of diagnostic methods for HPV status determination in head and neck squamous cell carcinoma (HNSCC). From traditional p16 immunohistochemistry to innovative liquid biopsies, discover the critical role these advancements play in prognosis, treatment planning, and improving patient outcomes.

Look into this essential topic and see how these insights could revolutionize clinical practices.

#SyenzaNews #oncology #HealthTech #HealthcareInnovation

oral health Africa
    

Oral Health in Africa: Promoting Collaborative Solutions

🦷 Is oral health taking a back seat in public health discussions in Africa?

A new article reveals alarming statistics about the high prevalence of untreated dental diseases across the continent and a critical shortage of oral health professionals. It emphasizes the urgent need for collaborative action among healthcare providers and policy-makers to integrate oral health into broader public health frameworks.

Discover how strengthening partnerships can pave the way for improved health outcomes and resource allocation in oral health.

#SyenzaNews #globalhealth #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.